Drug:
Reaction: BLOOD GLUCOSE INCREASED
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26531314 |
48 | 1 | |
Blood glucose decreased, Blood glucose increased, Nausea, Thirst, |
||||
INSULIN LISPRO, |
||||
| 102 | 26532089 |
US |
71 | 2 |
Stress, Pain, Blood glucose increased, Wrong technique in product usage process, Blood glucose decreased, |
||||
INSULIN LISPRO-AABC, INSULIN LISPRO-AABC, |
||||
| 103 | 26534014 |
CN |
55 | 2 |
Neutrophil count decreased, White blood cell count decreased, Platelet count decreased, Blood glucose increased, Glycosylated haemoglobin increased, Cough, Productive cough, Bronchitis, Myelosuppression, Breast cancer metastatic, |
||||
INAVOLISIB, PALBOCICLIB, FULVESTRANT, |
||||
| 104 | 26534116 |
CA |
49 | 1 |
Asthenia, Blood glucose increased, Blood pressure increased, Blood pressure systolic increased, Body temperature increased, Cardiac disorder, Chest pain, Depression, Fatigue, Gait disturbance, Hepatic lesion, Injection site haemorrhage, Injection site mass, Injection site pain, Lethargy, Needle issue, Neoplasm progression, Post procedural infection, Skin lesion, Syringe issue, Tachycardia, Underdose, Weight decreased, Inappropriate schedule of product administration, Drug ineffective, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, AMLODIPINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, |
||||
| 105 | 26534188 |
US |
69 | 2 |
Hypoaesthesia, Tremor, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 106 | 26534313 |
CN |
1 | |
Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood glucose increased, Blood creatine phosphokinase increased, Blood lactate dehydrogenase increased, |
||||
INCLISIRAN, |
||||
| 107 | 26534545 |
2 | ||
Flushing, Blood glucose increased, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 108 | 26534576 |
1 | ||
Surgery, Blood glucose increased, |
||||
| 109 | 26534648 |
66 | 2 | |
Oropharyngeal pain, Stomatitis, Blood glucose increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 110 | 26534838 |
US |
73 | 1 |
Blood glucose increased, Device issue, Intentional product use issue, Drug ineffective, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 111 | 26534987 |
US |
71 | 2 |
Rotator cuff syndrome, Condition aggravated, Increased appetite, Brain fog, Vulvovaginal pruritus, Abdominal pain upper, Lipids increased, Blood glucose increased, Blood glucose increased, Glucose tolerance impaired, Vision blurred, Headache, Nausea, Nausea, Vomiting, Fatigue, Fatigue, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 112 | 26535183 |
US |
68 | 2 |
Atrial fibrillation, Transfusion, Hypotension, Positive airway pressure therapy, Cough, Anxiety, Insomnia, Oropharyngeal discomfort, Laryngitis, Blood glucose increased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, CABOZANTINIB, NIVOLUMAB, LISINOPRIL, |
||||
| 113 | 26535194 |
US |
59 | 2 |
Hypertension, COVID-19, Impaired gastric emptying, Metabolic disorder, Postprandial hypoglycaemia, Illness, Body temperature decreased, Vomiting, Alopecia, Dehydration, Headache, Blood glucose increased, Autoimmune disorder, Antinuclear antibody positive, Psoriasis, Sinusitis, Influenza, Dumping syndrome, Inappropriate schedule of product administration, Therapeutic response decreased, Overdose, Drug ineffective, Product use issue, |
||||
IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, TIRZEPATIDE, DULAGLUTIDE, LIRAGLUTIDE, |
||||
| 114 | 26535339 |
US |
77 | 2 |
Blood glucose increased, Illness, Hypoacusis, Wrong technique in product usage process, Visual impairment, |
||||
INSULIN LISPRO, |
||||
| 115 | 26535385 |
US |
20 | 1 |
Weight increased, Blood glucose increased, Fluid retention, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, SOMATROPIN, LEVOCARNITINE, LEVOCARNITINE ORAL, PREDNISONE, TESTOSTERONE ENANTHATE, |
||||
| 116 | 26535387 |
US |
30 | 1 |
Sepsis, Blood glucose increased, Skin ulcer, Oedema peripheral, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, ALBUTEROL SULFATE, ALBUTEROL, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, FLUCONAZOLE, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MODAFINIL, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, ERGOCALCIFEROL, ARMODAFINIL, ALBUTEROL SULFATE AND BUDESONIDE, TIRZEPATIDE, INSULIN LISPRO, BENZALKONIUM, INSULIN GLARGINE, PITOLISANT HYDROCHLORIDE, FUROSEMIDE, |
||||
| 117 | 26535510 |
US |
2 | |
Blood glucose increased, Mental impairment, |
||||
EMPAGLIFLOZIN, |
||||
| 118 | 26535785 |
59 | 1 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 119 | 26527692 |
43 | 2 | |
Thirst, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 120 | 26528016 |
US |
||
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 121 | 26528553 |
US |
76 | 2 |
Blood glucose increased, Heart rate increased, |
||||
POMALIDOMIDE, |
||||
| 122 | 26528692 |
IN |
||
Metabolic acidosis, Urine output decreased, Peripheral sensorimotor neuropathy, Myopathy, Rhabdomyolysis, Liver injury, Blood glucose increased, |
||||
| 123 | 26528897 |
US |
53 | 1 |
Blood glucose increased, Product complaint, |
||||
INSULIN HUMAN, INSULIN HUMAN, |
||||
| 124 | 26528898 |
US |
1 | |
Blood glucose increased, Product availability issue, Product administration interrupted, |
||||
INSULIN HUMAN, |
||||
| 125 | 26529004 |
79 | ||
Blood glucose increased, Insomnia, Haemoglobin increased, Haematocrit increased, Energy increased, Headache, Asthenia, |
||||
| 126 | 26529083 |
US |
74 | 2 |
Blood glucose increased, |
||||
LENALIDOMIDE, |
||||
| 127 | 26529142 |
73 | ||
Insomnia, Vision blurred, Blood pressure increased, Blood glucose increased, Balance disorder, Impaired driving ability, Unevaluable event, Nausea, Abdominal pain upper, Dizziness, |
||||
RESMETIROM, FAMOTIDINE, ROSUVASTATIN, CLONIDINE, METOPROLOL TARTRATE, METOPROLOL, INSULIN LISPRO, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PIOGLITAZONE, GABAPENTIN, CETIRIZINE HYDROCHLORIDE, |
||||
| 128 | 26529636 |
US |
82 | 2 |
Neuropathy peripheral, Fall, Dental prosthesis removal, Road traffic accident, Blood glucose increased, Muscle atrophy, |
||||
EVOLOCUMAB, |
||||
| 129 | 26529650 |
US |
1 | |
Glycosylated haemoglobin increased, Blood glucose increased, |
||||
PEGVALIASE-PQPZ, ALBUTEROL SULFATE, AMITRIPTYLINE HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, LOSARTAN POTASSIUM, EPINEPHRINE, FAMOTIDINE, FENOFIBRATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, NAPROXEN, NAPROXEN SODIUM, RIMEGEPANT SULFATE, OLOPATADINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE OPHTHALMIC, DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG, SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE, UBROGEPANT, |
||||
| 130 | 26529697 |
BR |
1 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 131 | 26529702 |
62 | 1 | |
Ketoacidosis, Syncope, Hypoglycaemia, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 132 | 26529791 |
US |
9 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 133 | 26529801 |
US |
68 | 2 |
Hepatic cancer, Visual impairment, Blood glucose increased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 134 | 26529997 |
US |
64 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 135 | 26530897 |
6 | 1 | |
Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, |
||||
| 136 | 26523156 |
US |
76 | 2 |
Blood glucose increased, |
||||
CAPIVASERTIB, |
||||
| 137 | 26523554 |
US |
66 | 1 |
Drug ineffective, Blood glucose increased, Glycosylated haemoglobin increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 138 | 26523673 |
TH |
2 | |
White blood cell count decreased, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Mean cell haemoglobin concentration decreased, Platelet count decreased, Blood creatinine increased, Carcinoembryonic antigen increased, Blood glucose increased, Lung opacity, Cardiomegaly, Aortic arteriosclerosis, Spinal osteoarthritis, |
||||
OSIMERTINIB, |
||||
| 139 | 26524781 |
US |
68 | 1 |
Expired product administered, Drug ineffective, Infusion site pain, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO-AABC, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 140 | 26524895 |
US |
47 | 2 |
Blood glucose increased, |
||||
INSULIN HUMAN, INSULIN HUMAN, |
||||
| 141 | 26525174 |
US |
75 | 2 |
Blood glucose increased, Peripheral swelling, Blood pressure increased, Injection site bruising, Condition aggravated, Contraindicated product administered, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, LISINOPRIL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, |
||||
| 142 | 26525240 |
US |
71 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 143 | 26525265 |
US |
2 | |
Blood glucose increased, |
||||
INSULIN HUMAN, |
||||
| 144 | 26525270 |
US |
2 | |
Blood glucose increased, Device effect incomplete, |
||||
INSULIN HUMAN, |
||||
| 145 | 26525489 |
ZA |
57 | 2 |
Ascites, Oedema peripheral, Renal impairment, Hypoglycaemia, Tremor, Hunger, Blood glucose increased, Weight decreased, Off label use, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, CARVEDILOL, |
||||
| 146 | 26525794 |
CN |
84 | 1 |
Macular degeneration, Visual impairment, Vision blurred, Hypertension, Incorrect dose administered, Blood glucose increased, Insulin resistance, |
||||
INSULIN HUMAN, |
||||
| 147 | 26525814 |
US |
1 | |
Cholecystectomy, Drug ineffective for unapproved indication, Blood glucose increased, Injection site bruising, Product use in unapproved indication, |
||||
LIRAGLUTIDE, |
||||
| 148 | 26525863 |
US |
67 | 1 |
Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 149 | 26525876 |
US |
1 | |
Blood glucose increased, Glycosylated haemoglobin increased, Poor quality sleep, Product dose omission issue, |
||||
EMPAGLIFLOZIN, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 150 | 26525935 |
CN |
67 | 2 |
Syncope, Blood glucose increased, Device delivery system issue, Device issue, Drug diversion, |
||||
INSULIN ASPART, INSULIN ASPART, INSULIN ASPART, |
||||
| 151 | 26525990 |
US |
63 | 2 |
Renal failure, Heart transplant, Abdominal distension, Blood glucose increased, Abdominal pain, |
||||
INSULIN ASPART, INSULIN GLARGINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 152 | 26526004 |
33 | 2 | |
Nausea, Blood glucose increased, Maternal exposure during pregnancy, Urine ketone body present, Headache, |
||||
INSULIN LISPRO, |
||||
| 153 | 26526482 |
US |
||
Weight increased, Hunger, Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 154 | 26526603 |
US |
63 | 2 |
Blood glucose increased, Nausea, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, EVOLOCUMAB, INSULIN GLARGINE, |
||||
| 155 | 26526664 |
68 | 2 | |
Coronary artery occlusion, Cardiac disorder, Blood glucose increased, Vomiting, Product dose omission issue, Off label use, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 156 | 26521970 |
US |
1 | |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 157 | 26522017 |
US |
2 | |
Blood glucose increased, Device issue, |
||||
INSULIN GLARGINE, |
||||
| 158 | 26521299 |
US |
73 | 1 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 159 | 26521303 |
US |
52 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 160 | 26521305 |
US |
59 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 161 | 26521318 |
US |
74 | 2 |
Arthritis, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 162 | 26521424 |
US |
64 | 2 |
Visual impairment, Cataract, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 163 | 26521441 |
US |
2 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 164 | 26521443 |
US |
72 | 2 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
| 165 | 26521514 |
US |
77 | 2 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 166 | 26521656 |
US |
2 | |
Blood glucose increased, Product dose omission in error, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 167 | 26521657 |
US |
88 | 1 |
Blood glucose increased, Device mechanical issue, |
||||
INSULIN GLARGINE, |
||||
| 168 | 26521769 |
US |
81 | 2 |
Blood glucose increased, Device issue, Stress, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 169 | 26521920 |
US |
2 | |
Contrast media allergy, Blood glucose abnormal, Drug ineffective, Blood glucose increased, Intentional dose omission, |
||||
INSULIN GLARGINE, PREDNISONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 170 | 26521925 |
US |
68 | 2 |
Blood glucose increased, Visual impairment, Eye operation, Device issue, |
||||
INSULIN GLARGINE, INSULIN DEGLUDEC, INSULIN DETEMIR, |
||||
| 171 | 26516984 |
US |
74 | 2 |
Blood glucose increased, |
||||
RISANKIZUMAB-RZAA, |
||||
| 172 | 26517046 |
68 | 2 | |
Atrial fibrillation, Transfusion, Hypotension, Sleep disorder, Anxiety, Oropharyngeal discomfort, Laryngitis, Blood glucose increased, Cough, |
||||
LISINOPRIL, CABOZANTINIB, NIVOLUMAB, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 173 | 26517061 |
CN |
55 | 2 |
Neutrophil count decreased, White blood cell count decreased, Platelet count decreased, Blood glucose increased, |
||||
FULVESTRANT, FULVESTRANT, INAVOLISIB, PALBOCICLIB, |
||||
| 174 | 26517202 |
62 | ||
Blood glucose increased, Therapy interrupted, Product availability issue, |
||||
LISINOPRIL, HYDROCHLOROTHIAZIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 175 | 26517203 |
57 | ||
Blood glucose increased, Device mechanical issue, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ROSUVASTATIN, |
||||
| 176 | 26517205 |
71 | ||
Blood glucose increased, Drug ineffective, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 177 | 26517369 |
66 | ||
Blood glucose increased, Device issue, Device delivery system issue, Device mechanical issue, |
||||
| 178 | 26517385 |
58 | ||
Blood glucose increased, Product use issue, Device mechanical issue, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 179 | 26517474 |
69 | ||
Blood glucose increased, Device mechanical issue, Product dose omission issue, |
||||
| 180 | 26517476 |
|||
Blood glucose increased, Product dose omission issue, Product availability issue, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 181 | 26517510 |
73 | ||
Blood glucose increased, Product dose omission issue, Device mechanical issue, |
||||
| 182 | 26517514 |
|||
Blood glucose increased, |
||||
| 183 | 26517517 |
52 | ||
Blood glucose increased, Product use issue, Device mechanical issue, |
||||
| 184 | 26517657 |
75 | ||
Glycosylated haemoglobin increased, Injection site pain, Blood glucose increased, Device mechanical issue, Device delivery system issue, |
||||
ATORVASTATIN CALCIUM, EZETIMIBE, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 185 | 26517663 |
|||
Blood glucose increased, Drug dose omission by device, Device mechanical issue, |
||||
| 186 | 26517664 |
55 | ||
Blood glucose increased, Incorrect dose administered, Device mechanical issue, |
||||
| 187 | 26517666 |
89 | ||
Blood glucose increased, Incorrect dose administered by device, Device delivery system issue, |
||||
| 188 | 26517677 |
72 | ||
Blood glucose increased, Device mechanical issue, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, EMPAGLIFLOZIN, |
||||
| 189 | 26517687 |
US |
||
Anal incontinence, Blood glucose increased, Diarrhoea, |
||||
GLIMEPIRIDE, |
||||
| 190 | 26517960 |
EU |
7 | |
Diabetes mellitus, Blood glucose increased, |
||||
BUROSUMAB, |
||||
| 191 | 26518332 |
US |
||
Blood glucose increased, Condition aggravated, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 192 | 26518558 |
US |
1 | |
Blood glucose increased, |
||||
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE, |
||||
| 193 | 26520129 |
US |
2 | |
Cerebrovascular accident, Blood glucose increased, Blood pressure increased, Fatigue, Disease progression, |
||||
OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, SPIRONOLACTONE, SPIRONOLACTONE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LISINOPRIL, MAGNESIUM HYDROXIDE, POLYETHYLENE GLYCOL 3350, ONDANSETRON HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, APREPITANT, FOSAPREPITANT DIMEGLUMINE, FAMOTIDINE, CETIRIZINE HYDROCHLORIDE, OLANZAPINE, OLANZAPINE PAMOATE, ROSUVASTATIN CALCIUM, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN ASPART, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, MAGNESIUM, |
||||
| 194 | 26520162 |
US |
2 | |
Catheter site thrombosis, Arthralgia, Blood glucose increased, |
||||
CAPIVASERTIB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, ALPRAZOLAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FULVESTRANT, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OXYCODONE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, |
||||
| 195 | 26520189 |
PR |
1 | |
Blood glucose increased, |
||||
PREDNISONE, |
||||
| 196 | 26520344 |
US |
56 | 2 |
Postmenopausal haemorrhage, Steroid therapy, Blood glucose increased, Muscle spasms, Migraine, Nausea, |
||||
LIRAGLUTIDE, LIRAGLUTIDE, |
||||
| 197 | 26520525 |
US |
2 | |
Skin exfoliation, Blood glucose increased, Infection, Weight decreased, |
||||
RISANKIZUMAB-RZAA, EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 198 | 26520830 |
77 | 1 | |
Renal impairment, Loss of consciousness, Hepatic function abnormal, White blood cell count increased, Red blood cell count decreased, Mean cell volume increased, Mean cell haemoglobin increased, Mean platelet volume increased, Neutrophil count increased, Monocyte count increased, Red blood cell count increased, C-reactive protein increased, Blood pH increased, PCO2 decreased, PO2 decreased, Lymphocyte percentage decreased, Blood sodium increased, Blood potassium increased, Blood glucose increased, Myoglobin blood increased, Troponin T increased, Brain natriuretic peptide increased, Interleukin level increased, Dyskinesia, Productive cough, Tachypnoea, Arrhythmia, Oedema peripheral, Aphasia, Tongue coated, Extensor plantar response, Sputum retention, |
||||
EDOXABAN TOSYLATE, |
||||
| 199 | 26524563 |
43 | 1 | |
Aspartate aminotransferase increased, Alanine aminotransferase increased, Therapy cessation, Blood glucose increased, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 200 | 26512209 |
US |
8 | 2 |
Blood glucose decreased, Blood glucose increased, Incorrect dose administered, |
||||
SOMATROPIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28